Regentis Biomaterials (RGNT) Assets Average (2025)

Regentis Biomaterials (RGNT) reported Assets Average of $4.0 million for Q4 2025.

Regentis Biomaterials (RGNT) Assets Average (2025) Analysis & Trends

Regentis Biomaterials (RGNT) has 1 years of Assets Average data on file, last reported at $4.0 million in Q4 2025.

  • Assets Average for Q4 2025 came in at $4.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $4.0 million (changed N/A YoY), and the FY2025 annual result was $4.0 million, changed N/A from the prior year.
  • Assets Average was little changed at $4.0 million in Q4 2025 per RGNT's latest filing.
  • Over five years, Assets Average peaked at $4.0 million in Q4 2025 and troughed at $4.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 20.28 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 52.84 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 38.75 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 8.64 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 4.19 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 14.20 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 12.45 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 6.27 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 19.95 Bn
10 Regentis Biomaterials 3.72 Mn -3.66 Mn - 4.05 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.05 Mn